Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent

标题
Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent
作者
关键词
Biotinylated G3 PAMAM dendrimer, Celecoxib, Temozolomide resistant glioma, COX-2 expression, Prostaglandin PGE, 2, Nematode , Caenorhabditis elegans, In vitro and in vivo studies
出版物
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 152, Issue -, Pages 105439
出版商
Elsevier BV
发表日期
2020-06-30
DOI
10.1016/j.ejps.2020.105439

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started